Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Australian Shares Trade Higher

Published 22/09/2021, 11:19 am
Updated 22/09/2021, 11:21 am
© Reuters.

By Oliver Gray

Investing.com - The S&P/ASX 200 added 19.20 points or 0.26% to 7293.00 in early deals on Wednesday, extending slight gains of 0.25% in the previous session as traders remained cautious ahead of this week’s U.S. Federal Reserve meeting, while closely monitoring the risks from China’s Evergrande Group (HK:3333) crisis.

In coronavirus news, New South Wales added 1035 cases, with first dose vaccinations at 83% as health authorities mandated a week-long lockdown in 3 local government areas on Tuesday after a coronavirus-infected authorised worker with a valid permit flew from Sydney to Ballina on Saturday and was active in the community. Victoria added 628 cases as fears that the virus infections could explode amid mass construction protests take place in Melbourne.

Among stocks, Clinuvel Pharmaceuticals Ltd (ASX:CUV) added 3.35%. The financial sector weighed, with Commonwealth Bank Of Australia (ASX:CBA), National Australia Bank Ltd (ASX:NAB) and Westpac Banking Corp (ASX:WBC) down 0.72%, 0.96% and 1.07% respectively. Meantime, Zip Co Ltd (ASX:Z1P) added 0.16% after announcing that it has made its entry to the Indian market.

ASX 200 Futures were up 24.5 points or 0.34%.

In New Zealand, the NZX 50 added 6.3 points or 0.05% to 13170.64.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.